REFERENCES
- Hynes R O. Integrins: Versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11–25, [PUBMED], [INFOTRIEVE], [CSA]
- Lee J O, Rieu P, Arnaout M A, Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 1995; 80(4)631–638, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Berman A E, Kozlova N I, Morozevich G E. Integrins: Structure and signalling. Biochemistry 2003; 68(12)1284–1299, [PUBMED], [INFOTRIEVE], [CSA]
- Mould P., Askari J, Humphries M J. Molecular basis of ligand recognition by integrin α 5β 1. Biol Chem 2000; 275: 20324–20336, [CSA], [CROSSREF]
- Li R, Babu C R, Valentine K, Lear J D, Wand A J, Bennett J S, DeGrado W F. Characterisation of the monomeric form of the transmembrane and cytoplasmic domains of the integrin beta 3 subunit by NMR spectroscopy. Biochemistry 2002; 41(52)156, [CSA], [CROSSREF]
- Tamura R N, Rozzo C, Starr L, Chambers J, Reichardt L F, Cooper H M, Quaranta V. Epithelial integrin alpha 6 beta 4: Complete primary structure of alpha 6 and variant forms of beta 4. J Cell Biol 1990; 111: 1593–1604, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kuhn K, Eble J. The structural bases of integrin-ligand interactions. Trends Cell Biol 1994; 4(7)256–261, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Charalabopoulos K, Pignatelli M. Adhesion molecules and cancer. Arch Hell Med 2001; 18(1)16–19, [CSA]
- Wehrle-Haller B, Imhof B. Integrin dependent pathologies. J Pathol 2003; 200: 481–487, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24: 249–257, [CSA]
- Gogali A, Charalabopoulos K, Constantopoulos S. Integrins receptors in primary lung cancer. Exp Oncol 2004; 26(2)106–110, [PUBMED], [INFOTRIEVE], [CSA]
- Maree A, Fitzgerald D J. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: Where are we now?. Semin Vasc Med 2003; 3: 385–390, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li E, Brown S L, Stupack D G, Puente X S, Cheresh D A, Nemerow G R. Integrin avβ 1 is an adenovirus coreceptor. J Virol 2001; 75: 5405–5409, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Calvette J. Structures of integrin domains and concerted conformational changes in the bidirectional signalling mechanism of aIIbβ3. Exp Biol Med 2004; 229: 723–744, [CSA]
- Humphries M. Monoclonal antibodies as probes of integrin priming and activation. Biochem Soc Trans 2004; 32: 407–411, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sturgis E, Wei Q, Spitz M. Descriptive epidemiology and risk factors for head and neck cancer. Sem Oncol 2004; 31: 726–733, [CSA], [CROSSREF]
- Sanderson R J, Montague. Surgical management of head and neck malignancy. Surg J R Coll Edinb Irel 2004; 2: 7–14, [CSA]
- Cortesina G, Bussi M, Carlevato M T, Ferro S, Panizzut B, Cavalot A L, Gervasio C F, Marchisio P C. Significance of adhesion molecules as biological prognostic factors in locally advanced SCCHN. Acta Otol 1996; 116: 350–352, [CSA]
- Quon H, Liu F F, Cummings B J. Potential molecular prognostic markers in HNSCC. Head and Neck 2001; 147–159, [CSA], [CROSSREF]
- Rhee D, Wenig B, Smith R. The significance of immunohistochemically demonstrated nodal micrometastases in patient with SCCHN. Laryngoscope 2002; 112: 1970–1974, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Moon C, Oh Y, Roth J A. Current Status of Gene Therapy for Lung Cancer and Head and Neck Cancer. Clinical Cancer Research 2003; 9: 5055–5067, [PUBMED], [INFOTRIEVE], [CSA]
- Juliano R, Varner J. Adhesion molecules in cancer: The role of integrins. Curr Opin Cell Biol 1993; 5: 812–818, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mizejewski G. Role of integrins in cancer: Survey of expression patterns. Proceedings of the Soc Exp Biol Med 1999; 222: 124–138, [CSA], [CROSSREF]
- Felding-Habermann B. Integrin adhesion receptor in tumour metastasis. Clin Exp Metast 2003; 20: 203–213, [CSA], [CROSSREF]
- Maurizi M, Scambia G, Benedetti Panici P. EGF receptor expression in primary laryngeal cancer: Correlation with clinico-pathological features and prognostic significance. Int J Cancer 1992; 52: 862–866, [PUBMED], [INFOTRIEVE], [CSA]
- Grandis J R, Melhem M F, Gooding W E. Levels of TGF-alpha and EGFR protein in HNSCC and patient survival. J Natl Cancer Invest 1998; 90: 824–832, [CSA], [CROSSREF]
- Pignataro L, Pruneri G, Carboni N, Pignataro L, Capaccio P, Cesana B M, Neri A, Buffa R. Clinical relevance of cyclin-D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 1998; 16: 3069–3077, [PUBMED], [INFOTRIEVE], [CSA]
- Pavelic Z P, Gluckman J L. The role of p53 tumour suppressor gene in human head and neck tumorigenesis. Acta Otolaryngol 1997; 527: 21–24, [CSA]
- Marchisio P C, Bondanza S, Cremona O, Cancedda R, De Luca M. Polarised expression of integrins receptors (α 6β 4, α 2β 1, α 3β 1, α ν β 5) and their relationship with the cytoskeleton and basement membrane matrix in cultured human keratinocytes. J Cell Biol 1991; 112: 761–773, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carter W J, Waynes E A, Bouchard T S, Kour P. The role of integrins α 2β 1 and α 3β 1 in cell-cell and cell substrate adhesion of human epidermal cells. J Cell Biol 1990; 110: 1378–1340, [CSA], [CROSSREF]
- Haapasalmi K, Zhang K, Tonnesen M, Olerud J, Sheppard D, Salo T, Kramer R, Clark R A, Uitto V J, Larjava H. Keratinocytes in human wounds express avβ 6 integrin. J Invest Dermatol 1996; 106: 1–7, [CSA], [CROSSREF]
- Clark R, Ashcroft G, Spencer M-J, Larjaua H, Ferguson M. Re-epithelialisation of normal human excisional wounds is associated with a switch from α ν β 5 to α ν β 6 integrins. Br J Dermatol 1996; 135: 46–51, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jones J, Sugiyama M, Watt F M, Speight P M. Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. J Pathol 1993; 169: 235–243, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thomas G J, Jones J, Speight P M. Integrins and oral cancer. Oral Oncology 1997; 33: 381–388, [PUBMED], [INFOTRIEVE], [CSA]
- Walsh L, Coyne R, Xu L, Savage N. The role of adhesion molecules in oral cancer. Austr Dent J 1996; 41: 80–82, [CSA]
- Chainani-Wu N, Lagenaur L A, Penaranda M E, Palefsky J M. Integrin expression in oral hairy leukoplakia and normal tongue epithelium. Oral Dis 2000; 6: 234–240, [PUBMED], [INFOTRIEVE], [CSA]
- Ricci E, Cavalot A L, Sanvito F, Bussi M, Staffieri A, Cortesina G, Marchisio P C. Differential expression and topography of adhesion molecules in laryngeal and oropharyngeal carcinomas. Acta Otolaryngol 2002; 122: 234–240, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Maragou P, Bazopoulou-Kyrkanidou E, Panotopoulou E, Kakarantza-Angelopoulou E, Sklavounou-Andrikopoulou A, Kotaridis S. Alteration of integrin expression in oral squamous cell carcinomas. Oral Dis 1999; 5: 20–26, [PUBMED], [INFOTRIEVE], [CSA]
- Gasparoni A, Fonzi L, Scnheider G, Wertz P, Johnson G, Squier C. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture. Arch Biol 1996; 49(8)653–664, [CSA], [CROSSREF]
- Gianneli G, Milillo L, Marinosci F, Lo Muzio L, Serpico R, Antonaci S. Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa. J Biol Homeost Agents 2001; 15(4)375–380, [CSA]
- Carlevato M T, Trusolino L, Serini G, Valente G, Orlandi F, Angeli A, Cortesina G, Marchisio P C. Differential integrin expression in thyroid and laryngeal carcinomas. Anticancer Res 1996; 16(4C)2379–2384, [PUBMED], [INFOTRIEVE], [CSA]
- Lalonde E S, Beyer G, Friedlander P I, Kolls J K. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: An in vivo and in vitro study. Head and Neck 2002; 24(12)1038–1046, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jones J, Watt F, Speight P. Changes in the expression of α ν integrins in oral suamous cell carcinomas. J Oral Pathol Med 1997; 26: 63–68, [PUBMED], [INFOTRIEVE], [CSA]
- Regezi J, Ramos D, Pytela R, Dekker N, Jordan R. Tenascin and β 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 2002; 38: 332–336, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thomas G, Lewis P, Whawell S, Russel A, Sheppard D, Hart I, Speight P, Marshall J. Expression of the α ν β 6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 2001; 117: 67–80, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ramos D, But M, Regezi J, Schmidt B, Atakilit A, Dang D, Ellis D, Jordan R, Li X. Expression of integrin β 6 enhances invasive behaviour in oral squamous cell carcinoma. Matrix Biol 2002; 21: 297–307, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Xue H, Atakilit A, Zhu W, Li X, Ramos D, Pytela R. Role of the α ν β 6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun 2001; 288: 610–618, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang A, Patrone L, McDonald J A, et al. Expression of the integrin subunit α 9 in the murine embryo. Devel Dynam 1995; 204: 421–431, [CSA]
- Hakkinen L, Kainulainen T, Salo T, Grenman R, Larjava H. Expression of integrin α 9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 1999; 5: 210–217, [PUBMED], [INFOTRIEVE], [CSA]
- Stepp M, Zhu L. Upregulation of alpha 9 integrin and tenascin during epithelial regeneration after debridement in the cornea. J Histochem Cytochem 1997; 45: 189–201, [PUBMED], [INFOTRIEVE], [CSA]
- Liu S, Slepak M, Ginsberg M H. Binding of Paxillin to the alpha 9 Integrin Cytoplasmic Domain Inhibits Cell Spreading. J Biol Chem 2001; 276: 37086–37092, [PUBMED], [INFOTRIEVE], [CSA]
- Downer C S, Watt F M, Speight P M. Loss of alpha 6 and beta 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol 1993; 171(3)183–190, [PUBMED], [INFOTRIEVE], [CSA]
- Liebert M, Washington R, Wedemeyer G, Carey T E, Grossman H B. Loss of co-localization of alpha 6 beta4 integrin and collagen VII in bladder cancer. Am J Pathol 1994; 144: 787–795, [PUBMED], [INFOTRIEVE], [CSA]
- Bagutti C, Speight P M, Watt F M. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 1998; 186: 8–16, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dyce O, Ziober A, Weber R, Miyazaki K, Khariwala S, Feldman M, Ziober B. Integrins in head and neck squamous cell carcinoma invasion. Laryngoscope 2002; 112(11)2025–2032, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kosmehl H, Berndt A, Katenkamp D, Hyckel P, Stiller K-J, Gabler U, Langbein L, Reh T. Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study. J Oral Pathol Med 1995; 24: 343–348, [PUBMED], [INFOTRIEVE], [CSA]
- Garzino-Demo P, Carrozzo M, Trusolino L, Savoia P, Gandolfo S, Marchisio P C. Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol 1998; 34(3)204–210, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brooks P C, Montgomery A M, Rosenfeld M, et al. Integrin alphav beta3 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79(7)1157–1164, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Landowski T H, Olashaw N E, Agrawal D, Dalton W S. Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-kappa B (RelB/p50) in myeloma cells. Oncogene 2003; 22(16)2417–2421, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Damiano J S, Dalton W S. Integrin-mediated drug resistance in multiple myeloma. Leuk Lymphoma 2000; 38(1–2)71–81, [PUBMED], [INFOTRIEVE], [CSA]
- Ambrioc-Ristov A, Gabrilovac J, Cimbora-Zovko T, Osmak M. Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin α ν β 3 and coxxackie adenovirus receptor. Int J Cancer 2004; 110: 660–667, [CSA]
- Vitolo D, Ciocci L, Ferrauti P, Cicerone E, Gallo A, De Vincentiis M, Baroni C. α 5 integrin distribution and TGFβ 1 gene expression in supraglottic carcinoma: Their role in neoplastic local invasion and metastasis. Head Neck 2000; 22: 48–56, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Adachi M, Taki T, Ogawa E, et al. Expression of integrin alpha3 and alpha5 are associated with prognosis of non-small cell lung cancer. Proceedings of the 88th Annual Meeting of the American Association for Cancer Research 1997; 38: 329, [CSA]
- Kasono K, Blackwell J, Douglas J, Dmitriev I, Strong T, Reynolds P, Kropf D, Carvoll W, Peters G, Bucy R P, Curiel D, Krusnykh V. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin Cancer Res 1999; 5: 2571–2579, [PUBMED], [INFOTRIEVE], [CSA]